Skip to main content
. 2025 Mar 11;218:None. doi: 10.1016/j.ejca.2025.115275

Fig. 4.

Fig. 4

Neuroblastoma organoids representing clinically relevant molecular targets and their respective in vitro drug sensitivities. Every neuroblastoma model is depicted microscopically, as well as its circos plot (also available on (http://r2platform.com/pmc_nb_drugs/). Subsequent target matching selected drug sensitivities are demonstrated, as well as unexpected in vitro insensitivities. The dotted line represents maximum achievable plasma concentration.